Bioanalysis Zone sat down with Afshin Safavi, Founder and Chief Scientific Officer of BioAgilytix, at the recent Reid Bioanalytical Forum and discussed the challenges faced when running biomarker studies, whether the use of biomarkers in preclinical and clinical studies will continue and more. Click the link below to watch the full interview.
Services
Platforms
